Routine Tumor Testing for Homologous Recombination Deficiency in Patients With High Grade Epithelial Ovarian Cancer at a Statewide Gynecological Cancer Service in Western Australia: An Observational Study

ABSTRACT Background Poly‐ADP ribose polymerase inhibitors have been shown to improve progression‐free survival in patients with advanced high‐grade epithelial non‐mucinous ovarian cancers characterized by a deficiency in homologous recombination (HRD). Guidelines recommend all patients with advanced...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Kaamini Planisamy, Elena Ctori, Benhur Amanuel, Emma R. Allanson, Chloe Ayres, Martin Buck, Giselle Howard, Yee Leung, Tarek Meniawy, G. Raj K. A. Mohan, Cassandra B. Nichols, Navin David Pallayoor, Paul A. Cohen
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2025-09-01
Cyfres:	Cancer Reports
Pynciau:	homologous recombination deficiency (HRD) HRD testing ovarian cancer poly‐ADP ribose polymerase inhibitors
Mynediad Ar-lein:	https://doi.org/10.1002/cnr2.70335
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!